Technology area: Biotechnology & Pharmaceuticals
5 pending office actions • 5 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Universal Diagnostics, S.A. has 4 pending office actions in Biotechnology & Pharmaceuticals. These are distributed across 4 distinct examiners and 4 distinct art units. MUMMERT, STEPHANIE KANE is the busiest examiner, managing 1 pending office action. The portfolio shows a complete lack of concentration, with every one of the 4 pending office actions assigned to a different examiner and a different art unit. This distribution indicates a broad technical spread within the sector.
Because the busiest examiner, MUMMERT, STEPHANIE KANE, only handles 1 pending office action, the outcomes of the 4 pending office actions will be determined independently by 4 distinct examiners. This structure requires a prosecution strategy that accounts for the varied expectations and procedural nuances of 4 distinct examiners. The involvement of 4 distinct art units further confirms that the technical subject matter is spread across various specialized divisions. The 4 pending office actions represent a decentralized inventory where the success of one application is unlikely to be influenced by the others.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (40%) |
| §102 only | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MUMMERT, STEPHANIE KANE | 1 | 61.4% | +21.2% |
| AUGER, NOAH ANDREW | 1 | 36.2% | +42.6% |
| WISE, OLIVIA M. | 1 | 33.9% | +29.9% |
| PHAM, KHAI QUYNH TIEN | 1 | 0.0% | +0.0% |
| CASH, KAILEY ELIZABETH | 1 | 28.6% | +64.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17980755 | SYSTEMS AND METHODS FOR PREPARING BIOLOGICAL SAMPLES FOR GENETIC SEQUENCING | PHAM, KHAI QUYNH TIEN | 9d |
| 17744231 | METHODS FOR DISEASE DETECTION | CASH, KAILEY ELIZABETH | 29d |
| 18268578 | TAXONOMY-INDEPENDENT CANCER DIAGNOSTICS AND CLASSIFICATION USING MICROBIAL NUCLEIC ACIDS AND SOMATIC MUTATIONS | AUGER, NOAH ANDREW | 34d |
| 18252709 | CANCER DIAGNOSIS AND CLASSIFICATION BY NON-HUMAN METAGENOMIC PATHWAY ANALYSIS | WISE, OLIVIA M. | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17744231 | METHODS FOR DISEASE DETECTION | CASH, KAILEY ELIZABETH | 29d |
| 18268578 | TAXONOMY-INDEPENDENT CANCER DIAGNOSTICS AND CLASSIFICATION USING MICROBIAL NUCLEIC ACIDS AND SOMATIC MUTATIONS | AUGER, NOAH ANDREW | 34d |
| 18611068 | DETECTION OF COLORECTAL CANCER | MUMMERT, STEPHANIE KANE | — |
| 18252709 | CANCER DIAGNOSIS AND CLASSIFICATION BY NON-HUMAN METAGENOMIC PATHWAY ANALYSIS | WISE, OLIVIA M. | — |
| Art Unit | Apps |
|---|---|
| 1637 | 1 |
| 1687 | 1 |
| 1685 | 1 |
| 1684 | 1 |
| 1683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18611068 | DETECTION OF COLORECTAL CANCER | MUMMERT, STEPHANIE KANE | 1637 | §102 | Non-Final OA | — | Pending | Mar 20, 2024 |
| 18268578 | TAXONOMY-INDEPENDENT CANCER DIAGNOSTICS AND CLASSIFICATION USING MICROBIAL NUCLEIC ACIDS AND SOMATIC MUTATIONS | AUGER, NOAH ANDREW | 1687 | §101§103§112 | Final Rejection | 34d | Pending | Jun 20, 2023 |
| 18252709 | CANCER DIAGNOSIS AND CLASSIFICATION BY NON-HUMAN METAGENOMIC PATHWAY ANALYSIS | WISE, OLIVIA M. | 1685 | §101§103§112 | Non-Final OA | — | Pending | May 11, 2023 |
| 17980755 | SYSTEMS AND METHODS FOR PREPARING BIOLOGICAL SAMPLES FOR GENETIC SEQUENCING | PHAM, KHAI QUYNH TIEN | 1684 | §103§112 | Final Rejection | 9d | Pending | Nov 04, 2022 |
| 17744231 | METHODS FOR DISEASE DETECTION | CASH, KAILEY ELIZABETH | 1683 | §103§112 | Non-Final OA | 29d | Pending | May 13, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversal Diagnostics, S.A. has 5 pending office actions as of October 2026, spread across 5 art units and 5 examiners.
Stephanie Kane Mummert has the most, with 1 of Universal Diagnostics, S.A.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
